Literature DB >> 22415754

Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets.

Kate A Markey1, Motoko Koyama, Rachel D Kuns, Katie E Lineburg, Yana A Wilson, Stuart D Olver, Neil C Raffelt, Alistair L J Don, Antiopi Varelias, Renee J Robb, Melody Cheong, Christian R Engwerda, Raymond J Steptoe, Hayley S Ramshaw, Angel F Lopez, Javier Vega-Ramos, Andrew M Lew, Jose A Villadangos, Geoffrey R Hill, Kelli P A MacDonald.   

Abstract

Alloreactivity after transplantation is associated with profound immune suppression, and consequent opportunistic infection results in high morbidity and mortality. This immune suppression is most profound during GVHD after bone marrow transplantation where an inflammatory cytokine storm dominates. Contrary to current dogma, which avers that this is a T-cell defect, we demonstrate that the impairment lies within conventional dendritic cells (cDCs). Significantly, exogenous antigens can only be presented by the CD8(-) cDC subset after bone marrow transplantation, and inflammation during GVHD specifically renders the MHC class II presentation pathway in this population incompetent. In contrast, both classic and cross-presentation within MHC class I remain largely intact. Importantly, this defect in antigen processing can be partially reversed by TNF inhibition or the adoptive transfer of donor cDCs generated in the absence of inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415754     DOI: 10.1182/blood-2011-12-398164

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Autophagy and haematopoietic stem cell transplantation.

Authors:  Lucie Leveque; Laetitia Le Texier; Katie E Lineburg; Geoffrey R Hill; Kelli P A MacDonald
Journal:  Immunol Cell Biol       Date:  2014-11-04       Impact factor: 5.126

Review 2.  Biology of graft-versus-host responses: recent insights.

Authors:  Kelli P MacDonald; Warren D Shlomchik; Pavan Reddy
Journal:  Biol Blood Marrow Transplant       Date:  2013-01       Impact factor: 5.742

Review 3.  Cytokine mediators of chronic graft-versus-host disease.

Authors:  Kelli Pa MacDonald; Bruce R Blazar; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2017-06-30       Impact factor: 14.808

Review 4.  The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.

Authors:  Motoko Koyama; Geoffrey R Hill
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

Review 5.  Epigenetic Regulation of Dendritic Cell Development and Function.

Authors:  Yuanyuan Tian; Lijun Meng; Yi Zhang
Journal:  Cancer J       Date:  2017 Sep/Oct       Impact factor: 3.360

Review 6.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

7.  Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD.

Authors:  Lucie Leveque-El Mouttie; Motoko Koyama; Laetitia Le Texier; Kate A Markey; Melody Cheong; Rachel D Kuns; Katie E Lineburg; Bianca E Teal; Kylie A Alexander; Andrew D Clouston; Bruce R Blazar; Geoffrey R Hill; Kelli P A MacDonald
Journal:  Blood       Date:  2016-06-23       Impact factor: 22.113

Review 8.  The biology of graft-versus-host disease: experimental systems instructing clinical practice.

Authors:  Kate A Markey; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

9.  Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.

Authors:  Kate H Gartlan; Motoko Koyama; Katie E Lineburg; Karshing Chang; Kathleen S Ensbey; Rachel D Kuns; Andrea S Henden; Luke D Samson; Andrew D Clouston; Angel F Lopez; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood Adv       Date:  2019-10-08

10.  Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.

Authors:  Soung-Min Lee; Ha Young Park; Young-Sill Suh; Eun Hye Yoon; Juyang Kim; Won Hee Jang; Won-Sik Lee; Sae-Gwang Park; Il-Whan Choi; Inhak Choi; Sun-Woo Kang; Hwayoung Yun; Takanori Teshima; Byungsuk Kwon; Su-Kil Seo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.